These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38118030)

  • 1. Doxycycline Postexposure Prophylaxis for STIs in Women - Uncertain Benefit, Urgent Need.
    Marrazzo J
    N Engl J Med; 2023 Dec; 389(25):2389-2390. PubMed ID: 38118030
    [No Abstract]   [Full Text] [Related]  

  • 2. Total Antimicrobial Consumption in Doxycycline Postexposure Prophylaxis Cohorts and the Intensity of Screening for Bacterial Sexually Transmitted Infections.
    Vanbaelen T; Tsoumanis A; Kenyon C
    Clin Infect Dis; 2024 Mar; 78(3):803-805. PubMed ID: 37721151
    [No Abstract]   [Full Text] [Related]  

  • 3. High Interest in Doxycycline for Sexually Transmitted Infection Postexposure Prophylaxis in a Multicity Survey of Men Who Have Sex With Men Using a Social Networking Application.
    Spinelli MA; Scott HM; Vittinghoff E; Liu AY; Coleman K; Buchbinder SP
    Sex Transm Dis; 2019 Apr; 46(4):e32-e34. PubMed ID: 30870327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention.
    Oware K; Adiema L; Rono B; Violette LR; McClelland RS; Donnell D; Scoville CW; Odoyo J; Baeten JM; Bukusi E; Stewart J
    BMC Womens Health; 2023 Jun; 23(1):296. PubMed ID: 37270546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In brief: Doxycycline for STI post-exposure prophylaxis.
    Med Lett Drugs Ther; 2024 Jul; 66(1707):119-120. PubMed ID: 39008108
    [No Abstract]   [Full Text] [Related]  

  • 6. Pre and post-exposure prophylaxis with doxycycline: Exploring promises for prevention of sexually transmitted infections in the Indian context.
    Mehta H; Gupta M; Bishnoi A; Vinay K
    Indian J Dermatol Venereol Leprol; 2024; 90(5):671-672. PubMed ID: 38841971
    [No Abstract]   [Full Text] [Related]  

  • 7. Doxycycline Prophylaxis to Prevent Sexually Transmitted Infections in Women.
    Stewart J; Oware K; Donnell D; Violette LR; Odoyo J; Soge OO; Scoville CW; Omollo V; Mogaka FO; Sesay FA; McClelland RS; Spinelli M; Gandhi M; Bukusi EA; Baeten JM;
    N Engl J Med; 2023 Dec; 389(25):2331-2340. PubMed ID: 38118022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical Considerations in Implementing Doxycycline Postexposure Prophylaxis for the Prevention of Bacterial Sexually Transmitted Infections.
    Sugarman J; Taylor HA; Bachmann LH; Barbee LA; Cahill S; Celum C; Cohen SE; Faden RR; Luetkemeyer AF; Mayer KH; Mena L; Mermin J; Upshur R; Aral S
    Sex Transm Dis; 2024 Mar; 51(3):135-138. PubMed ID: 38079243
    [No Abstract]   [Full Text] [Related]  

  • 9. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.
    Molina JM; Charreau I; Chidiac C; Pialoux G; Cua E; Delaugerre C; Capitant C; Rojas-Castro D; Fonsart J; Bercot B; Bébéar C; Cotte L; Robineau O; Raffi F; Charbonneau P; Aslan A; Chas J; Niedbalski L; Spire B; Sagaon-Teyssier L; Carette D; Mestre SL; Doré V; Meyer L;
    Lancet Infect Dis; 2018 Mar; 18(3):308-317. PubMed ID: 29229440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic Use After Sex Might Not Prevent STIs Among Women.
    Harris E
    JAMA; 2024 Feb; 331(5):384-385. PubMed ID: 38231508
    [No Abstract]   [Full Text] [Related]  

  • 11. Important considerations regarding the widespread use of doxycycline chemoprophylaxis against sexually transmitted infections.
    Kong FYS; Kenyon C; Unemo M
    J Antimicrob Chemother; 2023 Jul; 78(7):1561-1568. PubMed ID: 37129293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correspondence on "A case for the inclusion of doxycycline post-exposure prophylaxis for sexually transmitted infections among men who have sex with men in sub-Saharan African countries' guidelines for the management of sexually transmitted infections" by "Dzinamarira
    Dzinamarira T; Moyo E; Murewanhema G
    Sex Transm Infect; 2024 Jan; 100(1):57. PubMed ID: 37833057
    [No Abstract]   [Full Text] [Related]  

  • 13. [Postexposure prophylaxis in daily clinical practice].
    Küpper MF; Stellbrink HJ; Kern WV; Müller MC
    Dtsch Med Wochenschr; 2015 Apr; 140(7):485-8. PubMed ID: 25826030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Doxycycline to Prevent Sexually Transmitted Infections According to Provider Characteristics.
    Pearson WS; Emerson B; Hogben M; Barbee L
    Emerg Infect Dis; 2024 Jan; 30(1):197-199. PubMed ID: 38147529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Do not overuse doxycycline as prophylaxis for uncomplicated sexually transmitted infections].
    Filén F; Eriksen J; Missailidis C
    Lakartidningen; 2024 Aug; 121():. PubMed ID: 39101261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postexposure Doxycycline for Sexually Transmitted Infections.
    Chiu YJ; Tsai CY
    N Engl J Med; 2023 Jul; 389(3):286. PubMed ID: 37467510
    [No Abstract]   [Full Text] [Related]  

  • 17. Postexposure Doxycycline for Sexually Transmitted Infections. Reply.
    Luetkemeyer AF; Cannon C; Celum C
    N Engl J Med; 2023 Jul; 389(3):286-287. PubMed ID: 37467511
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonoccupational Postexposure Prophylaxis and Preexposure Prophylaxis for Human Immunodeficiency Virus Prevention in Adolescents and Young Adults.
    Straub DM; Mullins TLK
    Adv Pediatr; 2019 Aug; 66():245-261. PubMed ID: 31230697
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sexually transmitted infections in emergency setting].
    Schwab D; Bally F; Selz Amaudruz F
    Rev Med Suisse; 2016 Aug; 12(526):1336-1340. PubMed ID: 28671779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections: Promises and Perils.
    Siguier M; Molina JM
    ACS Infect Dis; 2018 May; 4(5):660-663. PubMed ID: 29570279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.